|
|
||||||||
J Thorac Cardiovasc Surg 1997;113:821-829
© 1997 Mosby, Inc.
CARDIAC AND PULMONARY REPLACEMENT |
Supported by the Etablissement Français des Greffes.
Received for publication July 19, 1996 revisions requested Sept. 4, 1996; revisions received Dec. 16, 1996 accepted for publication Dec. 17, 1996. Address for reprints: Guy-Michel Mazmanian, MD, Centre Chirurgical Marie-Lannelongue, 133 Avenue de la Résistance, 92350 Le Plessis Robinson, France.
Abstract
Background: In non-heart-beating donor lung transplantation, postmortem warm ischemia poses a special challenge. Inhaled nitric oxide and pentoxifylline have been shown to attenuate ischemia-reperfusion injury after lung transplantation. We hypothesized that concomitant administration of inhaled nitric oxide and pentoxifylline would result in a synergistic effect on ischemia-reperfusion lung injury. Methods: Lungs were harvested from non-heart-beating donors after 30 minutes of in situ warm ischemia, flushed, and stored for 2 hours at 4° C before left lung transplantation in rats. Inhaled nitric oxide (30 ppm) was added during cadaver ventilation and reperfusion; pentoxifylline was given intravenously throughout reperfrsion. The following groups were studied (n = 8 each): control, pentoxifylline, nitric oxide, and nitric oxide + pentoxifylline. Hemodynamic indices and arterial blood gases were obtained after ligation of the right pulmonary artery. Lung myeloperoxidase and wet/dry ratio were measured after death. Results: All rats that did not receive nitric oxide died within 10 minutes after ligation. Inhaled nitric oxide significantly decreased pulmonary vascular resistance and improved recipient survival. Nitric oxide + pentoxifylline improved pulmonary vascular resistance, arterial oxygen tension, and survival even further and reduced lung myeloperoxidase as compared with the group that received nitric oxide only. Preservation solution flush time was significantly decreased in both groups receiving nitric oxide, suggesting that inhaled nitric oxide used during cadaver ventilation allows for a more even distribution of the preservation solution. Conclusion: We conclude that treatment with inhaled nitric oxide + pentoxifylline results in a synergistic protection from ischemia-reperfusion injury after non-heart-beating donor lung transplantation. This is likely the result of a dual action on the graft vasculature and neutrophil sequestration.
This article has been cited by other articles:
![]() |
S. Takashima, G. Koukoulis, H. Inokawa, M. Sevala, and T. M. Egan Inhaled nitric oxide reduces ischemia-reperfusion injury in rat lungs from non-heart-beating donors J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 132 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Egan Non-heart-beating lung donors: yes or NO? Ann. Thorac. Surg., November 1, 2000; 70(5): 1451 - 1452. [Full Text] [PDF] |
||||
![]() |
E. J. Birks, V. J. Owen, P. B. J. Burton, A. E. Bishop, N. R. Banner, A. Khaghani, J. M. Polak, and M. H. Yacoub Tumor Necrosis Factor-{alpha} Is Expressed in Donor Heart and Predicts Right Ventricular Failure After Human Heart Transplantation Circulation, July 18, 2000; 102(3): 326 - 331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |